Openwater, founded in 2016 by Dr. Mary Lou Jepsen, CEO and Founder, envisions a future where advancements in consumer electronics, semiconductor physics, and AI converge to make curing diseases a reality for all. Over the past seven years, this vision has led to promising clinical feasibility data, paving the way for breakthrough products that could revolutionize healthcare diagnostics and therapeutics. From tackling aggressive cancers and mental health disorders to addressing strokes, COVID/long COVID, and even cellular rejuvenation, Openwater is poised to transform the course of human health on a global scale.